Evaluate最新预测:2030年全球TOP10药企大洗牌,礼来、诺和诺德登顶,传统巨头让位

MedTrend医趋势
24 Jun

根据数据分析公司Evaluate Pharma的最新预测报告,到2030年,在糖尿病和肥胖症产品销售的强劲推动下,礼来(Eli Lilly)预计将跃升为全球处方药销量最高的企业,以显著优势稳居榜首。Evaluate在其《2025年世界展望》报告中预测,2030年礼来的处方药销售额将达到1130亿美元,远超排名第二的诺和诺德(Novo Nordisk)——后者2030年的预估销售额为840亿美元。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10